Leerink Swann resumes coverage on Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) with a Market Perform (from Suspended Coverage). PT $35.

Leerink ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE